Female Sexual Arousal Disorder

Vivus says sexual disorder drug fails to meet primary goalReuters - 10 hours ago… (VVUS.O: Quote, Profile, Research) on Friday said a mid-stage study of its drug for treatment of female sexual arousal disorder did not achieve statistical … Vivus Arousal Disorder Drug Fails Study Houston ChronicleVIVUS Announces Results of ALISTA Phase 2b Study Yahoo! News (press release)all 9 news articles

Read full story

Thermal Imaging Shatters Arousal Gender Gap MythNewswise (press release) - 4 hours ago… Binik’s PhD student, Tuuli Kukkonen, said, “This will help diagnose and treat sexual dysfunction in women, such as female sexual arousal disorder, which is …

Read full story

Market Report — In Play (VVUS)MSN Money - 10 hours ago… endpoint Co announces results of it's Phase 2b clinical study of its investigational drug Alista, for the treatment of female sexual arousal disorder, in women …

Read full story

AKIKO EZUKA Sex on Tuesday That Time of the MonthDaily Californian, CA - 9 hours ago… like depression, post-traumatic stress disorder and anxiety … an increase leads to the female body gaining … associated with feelings of sexual arousal and pleasure …

Read full story

Sifting through divergent theoriesThe Desert Sun, CA - 1 hour ago… that homosexuality per se is a mental disorder or based … chemicals that are key to sexual arousal in animals … When straight men smelled the female urine compound …

Read full story

VIVUS to Present at the UBS Global Life Sciences ConferencePR Newswire (press release), NY - 12 hours ago… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

VIVUS to Present at the UBS Global Life Sciences ConferencePharmaLive.com (press release), PA - 11 minutes ago… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

VIVUS to Present at the Oppenheimer Diabetes ConferenceDrug Newswire (press release), CT - 8 hours ago… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

VIVUS to Present at the Oppenheimer Diabetes ConferencePR Newswire (press release), NY - 7 hours ago… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

Emotional intimacy the key to better sexMonterey County Herald, CA - 2 hours ago… Female sexual dysfunction is categorized by low sexual desire, sexual arousal disorder, orgasmic disorder or sexual pain disorder, with the symptoms often …

Read full story

VIVUS to Present at the ThinkEquity Partners 4th Annual Growth …International News Service, Australia - Sep 11, 2006… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

VIVUS to Present at the ThinkEquity Partners 4th Annual Growth …PR Newswire (press release), NY - Sep 11, 2006… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS(R …

Read full story

VIVUS to Present at the ThinkEquity Partners 4th Annual Growth …Yahoo! News (press release) - 7 hours ago… for the treatment of obesity; ALISTA(TM), for which a Phase 2B study is ongoing for the treatment of Female Sexual Arousal Disorder (FSAD); Testosterone MDTS …

Read full story

Quest for the little pink pillLos Angeles Times, CA - 5 hours ago… and the researchers assessed their sexual functioning in … bupropion in 80 women with female orgasmic disorder … but also changes in desire, arousal and pleasure. …

Read full story

Sexual dysfunction: There's no need to despairBelfast Telegraph, United Kingdom - Sep 5, 2006… for the treatment of female sexual arousal disorders, but the results have been inconsistent. What it is Also known as global orgasmic disorder, it is …

Read full story

Zestra Laboratories, Inc. Closes on $6.0 Million Private Placement …Business Wire (press release), CA - 13 hours ago… gov by entering any of the following search terms: female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder or …

Read full story

Sexual dysfunction: There's no need to despairIndependent, UK - Sep 5, 2006… for the treatment of female sexual arousal disorders, but the results have been inconsistent. What it is Also known as global orgasmic disorder, it is …

Read full story